摘要
目的观察斯奇康对反复呼吸道感染(RRI)患儿血清免疫球蛋白水平的影响及临床疗效。方法将158例反复呼吸道感染患儿随机分成2组,对照组74例常规抗感染及对症治疗;斯奇康治疗组84例在常规治疗的基础上,臀部肌注斯奇康注射液。两组患儿在治疗前后均取静脉血2mL,用免疫散射比浊法检测血中IgG、IgA、IgM水平。结果治疗组治疗后RRI发作次数明显减少;患儿血清IgG、IgA、IgM水平提高。结论斯奇康对防治反复呼吸道感染有明显疗效,无严重毒副作用。
Objective To observe the impact of polysaccbaride nucleic acid fraction of bacillus calmette-guerin (13CA3-PSY) on the serum immunoglobulin of children suffered from repeated respiratory infection (RRI). Methods 158 children suffered from RRI were divided into two groups; the control grop ( n = 74) received the regular anti-infection treatment, the BCG-PSY group ( n = 84) received regular treatment plus injection of BCG-PSY. Every child in two groups was taken 2 mL vein blood before and after treatment to determine IgG, IgA, IgM by immunoturbidimetric assay. Results In BCG-PSY group,reoccurrence of RRI decreased greatly,and serum IgG, IgA, IgM increased after treatment. Conclusion BCG-PSY is an effective drug for RRI, no toxicity or less side effect.
作者
廖金轩
LIAO Jin-xuan (The People' s Hospital of Hechi city, Hechi 547000, China)
出处
《医学文选》
2006年第4期590-592,共3页
Anthology of Medicine